GenScript Biotech Corp 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:34 pm Unchanged |
2023-12-31 | 13G | Legend Biotech Corporation LEGN |
GenScript Biotech Corp | 174,497,556 47.990% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:02 pm Unchanged |
2022-12-31 | 13G | Legend Biotech Corporation LEGN |
GenScript Biotech Corp | 174,497,556 52.120% |
0 (Unchanged) |
Filing |
| 2022-03-11 5:02 pm Purchase |
2021-12-31 | 13G | Legend Biotech Corporation LEGN |
GenScript Biotech Corp | 174,497,556 57.100% |
4,500,000 (+2.65%) |
Filing |
| 2021-02-16 07:27 am Purchase |
2020-12-31 | 13G | Legend Biotech Corporation LEGN |
GenScript Biotech Corp | 169,997,556 64.300% |
169,997,556 (New Position) |
Filing |